- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Corneal pachymetry.
Displaying page 1 of 1.
EudraCT Number: 2017-005160-18 | Sponsor Protocol Number: RP101-200 | Start Date*: 2018-12-18 | |||||||||||
Sponsor Name:Redwood Pharma AB | |||||||||||||
Full Title: A Phase II, multicentre, randomised, placebo-controlled, double-masked trial of RP101 ophthalmic formulation versus vehicle in post-menopausal women with moderate to severe dry eye syndrome | |||||||||||||
Medical condition: moderate or severe dry eye syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) HU (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004247-24 | Sponsor Protocol Number: CCRG13-003 | Start Date*: 2015-01-27 | ||||||||||||||||
Sponsor Name:Antwerp University Hospital (UZA) | ||||||||||||||||||
Full Title: Translational stem cell research in ophthalmology - regenerating the anterior cornea through standardized transplantation of limbal epithelial stem cells: a phase II multicenter trial | ||||||||||||||||||
Medical condition: Primary and secondary Limbal Stem Cell Deficiencies | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001660-30 | Sponsor Protocol Number: CHL.3/01-2019/M | Start Date*: 2020-06-03 | |||||||||||
Sponsor Name:Sintetica S.A. | |||||||||||||
Full Title: A prospective, observer-masked, randomized clinical trial to investigate and compare the clinical efficacy of chloroprocaine 3% gel and tetracaine 0.5% eye drop as topical anesthetics in phacoemuls... | |||||||||||||
Medical condition: cataract surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001849-33 | Sponsor Protocol Number: SYL040012_III | Start Date*: 2012-04-09 | |||||||||||
Sponsor Name:Sylentis S.A.U. | |||||||||||||
Full Title: DOSE FINDING CLINICAL TRIAL WITH SYL040012 TO EVALUATE THE TOLERABILITY AND EFFECT ON INTRAOCULAR PRESSURE IN SUBJECTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA | |||||||||||||
Medical condition: Ocular Hypertension or Open-Angle Glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001149-15 | Sponsor Protocol Number: LevoDesa_05-2017 | Start Date*: 2018-07-31 | |||||||||||
Sponsor Name:NTC SRL | |||||||||||||
Full Title: Aqueous humour concentrations after topical apPlication of combinEd levofloxacin dexamethasone eye dRops and of its single components: a randoMized, assEssor-blinded, parallel-group study in patien... | |||||||||||||
Medical condition: Patients for which cataract surgery has been planned. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002574-52 | Sponsor Protocol Number: 1698-301-007 | Start Date*: 2019-08-01 | ||||||||||||||||
Sponsor Name:Allergan Ltd. | ||||||||||||||||||
Full Title: A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
Medical condition: Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Trial now transitioned) IE (Trial now transitioned) SE (Completed) CZ (Trial now transitioned) HU (Completed) PL (Trial now transitioned) DK (Trial now transitioned) BG (Trial now transitioned) IT (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002947-27 | Sponsor Protocol Number: SYL040012_IV | Start Date*: 2014-07-01 | |||||||||||
Sponsor Name:Sylentis S.A.U. | |||||||||||||
Full Title: A phase II, observer masked, active controlled study of SYL040012 for the treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension (SYLTAG) | |||||||||||||
Medical condition: Open angle glaucoma - intraocular pressure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003617-42 | Sponsor Protocol Number: BP25466 | Start Date*: 2011-12-14 | ||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd. | ||||||||||||||||||
Full Title: An adaptive, multi-center, randomized, investigator-masked, subject-masked, multiple-dose, placebo-controlled, parallel study to investigate efficacy, safety, tolerability and pharmacokinetics of... | ||||||||||||||||||
Medical condition: Primary open angle glaucoma or ocular hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) CZ (Prematurely Ended) BG (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
